Medigene AG
MDG1 | F
Overview
Corporate Details
- ISIN(s):
- DE000A40ESG2
- LEI:
- 391200I33JD2DKZGDX06
- Country:
- Germany
- Address:
- Lochhamer Straße 11, 82152 Planegg
- Website:
- https://medigene.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Medigene AG (FWB: MDG1) is a publicly listed, immuno-oncology platform company dedicated to developing t cell receptor (tcr)-guided therapies to effectively eliminate cancer Generation of optimal affinity 3S (specificity, sensitivity, and safety ) TCRs is the foundation for our integrated proprietary End-to-End Platform which includes multiple TCR generation and optimization technologies as well as product enhancement technologies. These 3S- TCRs show great potential for application across various modalities, including TCR-T cell engagers, as well as TCR-natural killer cell therapies and TCR-T therapies.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ANIMALCARE GROUP PLC | United Kingdom | ANCR | |
|
Annexin Pharmaceuticals AB | Sweden | ANNX | |
|
Apontis Pharma AG | Germany | APPH | |
|
Aptahem AB | Sweden | APTA | |
|
Arctic Bioscience | Norway | ABS | |
|
ArcticZymes Technologies | Norway | AZT | |
|
argenx SE | Netherlands (Kingdom of the) | 1AE | |
|
ARIX BIOSCIENCE PLC | United Kingdom | ARIX | |
|
AroCell AB | Sweden | AROC | |
|
Arterra Bioscience | Italy | ABS |